Financials
Financial year 2025
GFX Biocapital from Elsene, company number BE0736965814, closed financial year 2025 with a result of € 89,904 after tax. For that financial year GFX Biocapital recorded a gross margin of € 141,448 and equity of € 6,000. Compared with financial year 2024, the result moved from € 121,686 to € 89,904. The company is profitable. The buffer shrank hard: equity is 97 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
€ 6,000
▼ 97% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 89,904
▼ 26% vs 2024
Profit after tax over the fiscal year.
€ 721,605
▲ 73% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 315,670 paid out
More than the year’s profit went to the shareholders; reserves fell.
Debts at end 2025
€ 46
▲ 44% vs 2024
Loans from banks and other lenders, long and short.
€ 1,347
▼ 54% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 85,549
▲ 1% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 155,720 | € 192,750 | € 145,414 | € 141,448 | ▼ 3% |
| Profit after taxes | € 119,504 | € 146,109 | € 121,686 | € 89,904 | ▼ 26% |
| Equity | € 507,499 | € 580,668 | € 231,765 | € 6,000 | ▼ 97% |
| Total debts | € 96,541 | € 90,895 | € 487,383 | € 802,612 | ▲ 65% |
| Cash | € 523,695 | € 162,872 | € 417,496 | € 721,605 | ▲ 73% |
| Retained profit | € 501,499 | € 574,668 | € 225,765 | € 0 | ▼ 100% |
| Dividend | € 0 | € 72,941 | € 470,588 | € 315,670 | ▼ 33% |
| Bank debt | € 0 | € 394 | € 32 | € 46 | ▲ 44% |
| Balance sheet total | € 604,040 | € 671,562 | € 719,148 | € 808,612 | ▲ 12% |
Key figures of GFX Biocapital, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GFX Biocapital?
What happened at GFX Biocapital in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 89,904 (▼ 26% vs 2024). Source: NBB ↗
- New establishment in Elsene. KBO
- Grégoire Franoux became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 119,504 profit in 2022 to € 89,904 profit in 2025.
Paid € 138,444 in corporate taxes since 2022.
Best year ever: 2023, with € 146,109 profit.
Paid out € 859,199 in dividends to the owners in total.
A new publication or filing at GFX Biocapital? We notify you, reason included.
Follow GFX BiocapitalDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind GFX Biocapital is Grégoire Franoux.
Directors
According to the 2025 annual accounts
Grégoire Franoux
Director
since 2019
Establishments
Establishment units
Physical locations of this company
George Bergmannlaan 87
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0736.965.814
- VAT number
- BE 0736.965.814
- Registered office
- George Bergmannlaan 87, 1050 Elsene
- Names & denominations
- GFX Biocapital
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 October 2019
- Peppol
- Active · Active since 26 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Literaire creatie
Markt- en opinieonderzoek
Overige technische testen en toetsen
Overige vormen van onderwijs
Overige rechtskundige dienstverlening
Scheppende kunsten, m.u.v. ondersteunende diensten